SMB congratulates Khondrion on the start of the KHENERGY study, a phase 2 clinical trial of KH176 in MELAS/MIDD and mixed mitochondrial syndromes! For more information on the clinical trial please refer to the Press release from Khondrion.
“De bijdrage van SMB was een welkome steun in de rug voor onze patentaanvraag”
Jeroen Langevoort, NovioScanSMB congratulates Khondrion on the start of the KHENERGY study, a phase 2 clinical trial of KH176 in MELAS/MIDD and mixed mitochondrial syndromes! For more information on the clinical trial please refer to the Press release from Khondrion.